Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy for early-stage non-small cell lung cancer: A system review
Jingyi Gao, Chao Zhang, Zhigang Wei, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 4, pp. 849-865
Open Access | Times Cited: 12

Showing 12 citing articles:

Lung-Targeted Delivery of PTEN mRNA Combined with anti-PD-1-mediated Immunotherapy for In Situ Lung Cancer Treatment
Yue Hu, Xi He, Ping Chen, et al.
Acta Biomaterialia (2025)
Closed Access
Enhanced recovery after surgery for percutaneous CT-guided microwave ablation of lung tumors: A single-center retrospective cohort study
Huajian Peng, Meijing Wang, Shuyu Lu, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 651-657
Open Access | Times Cited: 4
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes
Kangle Zhu, Jingwei Shi, Rusong Yang, et al.
Neoplasia (2023) Vol. 46, pp. 100950-100950
Open Access | Times Cited: 11
Surgery or radiotherapy improves survival in elderly patients with early non-small cell lung cancer: A population-based analysis
Pingfan Shi, Ziye Li, Yanfei Zhang, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 4, pp. 1251-1257
Open Access | Times Cited: 3
Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC
Evangelia Bogatsa, George Lazaridis, Chrysoula Stivanaki, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1619-1619
Open Access | Times Cited: 2
Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Miaomiao Yang, Hongxin Cao, Congcong Wang, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 509-521
Open Access | Times Cited: 2
Local therapy combined with anti-PD-1 immunotherapy for advanced lung adenocarcinoma: A case report
Na Wu, Xiaoxin Yang, Yan Zhai, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 739-744
Open Access | Times Cited: 1
Combination low-dose cyclophosphamide with check-point blockade and ionizing radiation promote an abscopal effect in mouse models of melanoma
Xing Luo, Ming Zeng
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 718-725
Open Access | Times Cited: 1
Downregulation of MMP-9 by epicatechin can improve the radiosensitivity of non-small cell lung cancer
Anao Wu, Yongmei He, Huahua Zhou, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 4, pp. 1284-1292
Open Access | Times Cited: 1
Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic Targets
Neha Sharma, Rupa Mazumder, Pallavi Rai
Current Drug Targets (2024) Vol. 25, Iss. 15, pp. 1012-1026
Closed Access | Times Cited: 1
Perioperative immunotherapy for nonsmall cell lung cancer
Jingya Huang, Wenyuan Li, Hui Guo
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 1
Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimens or chemotherapy: A study based on the SEER database and multicentric real-world settings
Duanyang Peng, Le Xiong, Yuxi Luo, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 7, pp. 2110-2117
Open Access
Page 1

Scroll to top